INDUSTRIAL SCALE PROCESS OF CULTIVATING GANODERMA LUCIDUM MYCELIUM
申请人:Double Crane Biotechnology Co. Ltd
公开号:EP2997127B1
公开(公告)日:2018-12-05
Therapeutic Composition for Treating Cancers
申请人:Double Crane Biotechnology Co., LTD
公开号:US20140357604A1
公开(公告)日:2014-12-04
Disclosed herein is a composition that includes a novel combination of triterpenoids for the treatment or prophylaxis of a cancer. The triterpenoids includes at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS). The composition is suitable for the treatment or prophylaxis of colon cancer, hepatic cancer, breast cancer, lung cancer or leukemia.
US9198922B2
申请人:——
公开号:US9198922B2
公开(公告)日:2015-12-01
US9820443B2
申请人:——
公开号:US9820443B2
公开(公告)日:2017-11-21
[EN] PROCESS FOR PREPARING DELTA-7,9(11) STEROIDS FROM GANODERMA LUCIDUM AND ANALOGS THEREOF<br/>[FR] PROCÉDÉ DE PRÉPARATION DE STÉROÏDES DELTA-7,9(11) À PARTIR DE GANODERMA LUCIDUM ET D'ANALOGUES DE CEUX-CI
申请人:UNIV INDIANA RES & TECH CORP
公开号:WO2012044817A2
公开(公告)日:2012-04-05
Processes for preparing lanostane triterpenes from the medicinal mushroom Ganoderma lucidum, and related compounds are described. Compounds, compositions, and methods for treating cancer are also described.